Israeli Practice

Heller Ehrman has a long history of working with Israeli clients, and our attorneys have significant experience assisting them in business transactions, litigation, regulatory compliance and patent prosecution. We have a diverse group of attorneys located throughout our network of offices in the United States and abroad that understands the special needs of Israeli clients and can act as a bridge between Israeli companies and the U.S. market.

Our Israeli clients include established publicly traded companies, private emerging growth companies, venture funds and other investors. Our Israeli practice has focused mainly in the areas of life sciences, software, communications and Internet. We work closely with our clients to provide them with services that suit their special needs, and we have working relationships with leading law firms, accounting firms, venture funds and other professionals in Israel. In recent years we have represented Israeli clients in venture investments, public offerings, mergers and acquisitions, tax planning, licenses and other distribution agreements, FDA and other regulatory compliance, executive compensation, employment practices, intellectual property litigation, and patent and trademark prosecution.

Heller Ehrman has attorneys who are fluent in Hebrew and who maintain contacts with such major Israeli venture capital firms as Concord, Polaris, Giza, Tamir, and Fishman.

Representative Clients

• CeLight, Inc.
• Common Sense Ltd.
• Compugen, Inc. 
• F2Buy, Inc.
• Magnolia Broadband
• Medica Venture Partners
• Neurim Pharmaceuticals, S.A.
• NiTi Medical Technologies Ltd.
• Proneuron Biotechnology, Inc.
•  Selis Networks, Inc.
• Sol-Gel Technologies Ltd.
• Teva Pharmaceuticals Industries, Ltd.
• VisionCare Opthalmic Technologies Inc.
• Vsecure Technologies
• XTL BioPharmaceuticals